Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > First Grant Awarded By Kay Yow/WBCA Cancer Fund to be Announced at the Women’s NCAA Final Four in St. Louis

Abstract:
Grant will be used for early detection research in breast cancer patients

First Grant Awarded By Kay Yow/WBCA Cancer Fund to be Announced at the Women’s NCAA Final Four in St. Louis

St. Louis, MO | Posted on April 4th, 2009

The Kay Yow/Women's Basketball Coaches Association Cancer Fund and The V Foundation announce that Michael Welch, Ph.D. and John-Stephen Tyler, Ph.D. will be recipients of the first research grant awarded with money raised by the Kay Yow/WBCA Fund. Awarded during the NCAA Women's Final Four weekend in St. Louis, Missouri, the grant will be given to fund a breast cancer research project at the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital, also located in St. Louis.

The Kay Yow/WBCA Cancer Fund was created in 2007 by Kay Yow, the longtime North Carolina State women's basketball coach, in collaboration with the WBCA and The V Foundation for Cancer Research. "The Kay Yow/WBCA Cancer Fund, in partnership with The V Foundation, is thrilled to be allocating our first grant of $100,000 to Dr. Michael Welch from Washington University in St. Louis, Missouri. The women's basketball community is committed to finding an answer in the fight against women's cancers through raising money for scientific research as a collective whole. Thank you to everyone who has supported this truly wonderful cause," says Marsha Sharp, President of the Kay Yow/WBCA Cancer Fund.

The Kay Yow/WBCA Cancer Fund is dedicated to the fight against women's cancers through raising money for scientific research, assisting the underserved and unifying people for a common cause. "We are thrilled to have accomplished this tremendous feat in Kay's honor," said CEO of The V Foundation Nick Valvano. "It is a true tribute to Kay that so many people have embraced her cause and supported the Fund which she established."

This grant in particular will be used for a project titled "Targeted Nanoparticles Optimized for Breast Cancer Diagnosis and Therapy," in which the principal investigators will study methods to improve the diagnosis and treatment of breast cancer through nanotechnology.This research will be conducted in hopes that doctors will be able to find cancerous cells even before a mammogram can detect them.

"Thanks to the wonderful support of the Kay Yow/WBCA Cancer Fund and the V Foundation - we will be able to realize our goal of studying ways to earlier diagnose breast cancer using nanotechnology," says Timothy Eberlein, M.D., director of Siteman Cancer Center and the Bixby Professor and chairman of the Department of Surgery at the School of Medicine. "Our research also has opened the possibility of using this exciting new technology for targeted therapy, which promises to be more effective and less toxic. We are grateful to the Kay Yow/WBCH Cancer Fund and the V Foundation for having the confidence in our research to award this valuable support."

####

About Kay Yow/WBCH Cancer Fund
The Kay Yow/WBCA Cancer Fund is a 501 c(3) charitable organization committed to being a part of finding an answer in the fight against women’s cancers through raising money for scientific research, assisting the underserved and unifying people for a common cause.

About The V Foundation for Cancer Research

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, the legendary North Carolina State basketball coach and ESPN commentator. Since 1993, The Foundation has raised more than $80 million to fund cancer research grants nationwide. It awards 100 percent of direct cash donations and net proceeds of events directly to cancer research and related programs. The Foundation, which has received six consecutive top 4-star ratings from Charity Navigator, awards grants through a competitive awards process strictly supervised by a Scientific Advisory Board. For more information about The V Foundation, or to make a donation, please visit www.jimmyv.org.

About the WBCA

Founded in 1981, the WBCA promotes women’s basketball by unifying coaches at all levels to develop a reputable identity for the sport and to foster and promote the development of the game as a sport for women and girls. For additional information about the WBCA, please visit wbca.org.

About Siteman Cancer Center

Siteman Cancer Center is the only federally designated Comprehensive Cancer Center within a 240-mile radius of St. Louis. Siteman Cancer Center is composed of the combined cancer research and treatment programs of Barnes-Jewish Hospital and Washington University School of Medicine. Siteman has satellite locations in West County and St. Peters, in addition to its full-service facility at Washington University Medical Center on South Kingshighway.

Contacts:
Sherrie Mazur
Director of Marketing and Communication
The V Foundation
919/380-9509

Copyright © NCAA

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

Siteman Cancer Center

Barnes-Jewish Hospital

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024

Atomic force microscopy in 3D July 5th, 2024

Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project